A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 26, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Myeloid Leukemia
Trial Locations (13)

10676

ACTIVE_NOT_RECRUITING

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 244339, Athens

11522

ACTIVE_NOT_RECRUITING

General Anti-cancer Hospital Agios Savvas /ID# 244408, Athens

11527

ACTIVE_NOT_RECRUITING

General Hospital of Athens Gennimatas /ID# 245968, Athens

ACTIVE_NOT_RECRUITING

General Hospital of Athens Laiko /ID# 244338, Athens

ACTIVE_NOT_RECRUITING

General Hospital of Athens Laiko - Hematology Location /ID# 244234, Athens

12462

ACTIVE_NOT_RECRUITING

University General Hospital Attikon /ID# 248265, Athens

25443

ACTIVE_NOT_RECRUITING

Olympion General Clinic /ID# 268392, Pátrai

26504

COMPLETED

University General Hospital of Patras /ID# 244335, RION Patras Achaia

45500

ACTIVE_NOT_RECRUITING

University General Hospital of Ioannina /ID# 244336, Ioannina

56429

RECRUITING

Papageorgiou General Hospital /ID# 248266, Thessaloniki

57010

ACTIVE_NOT_RECRUITING

General Hospital of Thessaloniki George Papanikolaou /ID# 244237, Thessaloniki

68100

ACTIVE_NOT_RECRUITING

General University Hospital of Alexandroupolis /ID# 244235, Alexandroupoli

71500

COMPLETED

University General Hospital of Heraklion PA.G.N.I /ID# 244337, Heraklion

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY